N1'-(p-[18F]fluorobenzyl)naltrindole (p-[18F]BNTI) as a potential PET imaging agent for DOP receptors

Journal of Labelled Compounds and Radiopharmaceuticals

Volumn 49, Issue 10, 2006, Pages 857-866

  Akgün, Eyup ^a,b,c   Sajjad, Munawwar ^a,b,d   Portoghese, Philip S ^c  

^a VETERANS AFFAIRS MEDICAL CENTER   (United States)

^b UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

^c UNIVERSITY OF MINNESOTA   (United States)

^d UNIVERSITY AT BUFFALO   (United States)

Author keywords

Delta opioid receptors; FBNTI; Fluorine 18; Positron emission tomography

Indexed keywords

CATALYSIS; FLUORINE;

DELTA-OPIOID RECEPTOR; FBNTI; FLUORINE-18; IMAGING AGENT; OPIOIDS; PET IMAGING; PHASE TRANSFER CATALYSIS; RECEPTOR ANTAGONISTS; SYNTHESISED; TARGET COMPOUND;

POSITRON EMISSION TOMOGRAPHY;

(4 FLUOROBENZYL)NALTRINDOLE; DELTA OPIATE RECEPTOR; DELTA OPIATE RECEPTOR ANTAGONIST; ENKEPHALIN[2,5 DEXTRO PENICILLAMINE]; N 1' (4 FLUOROBENZYL)NATRINDOLE F 18; N 1' (4 FLUOROMETHYL) 17 (CYCLOPROPYLMETHYL) 6,7 DIDEHYDRO 4,5 EPOXY 3,14 DIHYDROXYINDOLO[2',3',6,7]MORPHINAN F 18; N 1' (4 FLUOROMETHYL) 17 (CYCLOPROPYLMETHYL) 6,7 DIDEHYDRO 4,5 EPOXY 3,24 DIHYDROXYINDOLO [2',3',6,7]MORPHINAN; NALTRINDOLE; RADIOISOTOPE; UNCLASSIFIED DRUG;

ARTICLE; BENZYLATION; BINDING AFFINITY; CATALYSIS; CELL STRAIN HEK293; CENTRAL NERVOUS SYSTEM; CONTROLLED STUDY; DRUG STRUCTURE; DRUG SYNTHESIS; HUMAN; HUMAN CELL; ISOTOPE LABELING; MOUSE; NONHUMAN; POSITRON EMISSION TOMOGRAPHY; PROTON NUCLEAR MAGNETIC RESONANCE; VAS DEFERENS;

EID: 33749504492     PISSN: 03624803     EISSN: 10991344     Source Type: Journal    
DOI: 10.1002/jlcr.1095     Document Type: Article

References (31)

1. Dhawan BN, Cesselin F, Raghubir R, Reisine T, Bradley PB, Portoghese PS, Hamon M. Pharmacol Rev 1996; 48: 567-592.
2. Gutstein HB, Akil H. Opioid analgesics. In Goodman and Gilman's The Pharmacologic Basis of Therapeutics (11th edn.), Brunton LL (ed.). The McGraw-Hill Companies, Inc.: New York, 2006; 547-590.
3. Feldman RS, Meyer JS, Quenzer LF. Principles of Neuropharmacology. Sinauer Associates, Inc.: Sutherland, Massachusetts, USA, 1997; 504.
4. Mansour A, Khachaturian H, Lewis ME, Akil H, Watson SJ. Trends Neurosci 1988; 11: 308-314.
5. Gavériaux C, Pelluso J, Simonin F, Kieffer B. FEBS Lett 1995; 369: 272-276.
6. Jiang Q, Takemori AE, Sultana M, Portoghese PS, Bowen WD, Mosberg HI, Porreca F. J Pharmacol Exp Ther 1991; 257: 1069-1075.
7. Mattia A, Vanderah T, Mosberg HI, Porreca F. J Pharmacol Exp Ther 1991; 258: 583-587.
8. Kieffer BL, Befort K, Gaveriaux-Ruff C, Hirth CG. Proc Natl Acad Sci USA 1992; 89: 12048-12052.
9. Evans CJ, Keith Jr DE, Morrison H, Magendzo K, Edwards RH. Science 1992; 18: 1952-1955.
10. Milligan G. Mol Pharmacol 2004; 66: 1-7.
11. Gomes I, Jordan BA, Gupta A, Rios C, Trapaidze N, Devi LA. J Mol Med 2001; 79: 226-242.
12. Jordan BA, Devi LA. Nature 1999; 399: 697-700.
13. Gomes I, Jordan BA, Gupta A, Trapaidze N, Nagy V, Devi LA. J Neurosci 2000; RC110-1-Rc110/5.
14. Bushan RG, Sharma SK, Xie Z, Daniels DJ, Portoghese PS. J Med Chem 2004; 47: 2969-2972.
15. Pascal G, Milligan G. Mol Pharmacol 2005; 68: 905-915.
16. Burns HD, Hamill TG, Eng W-si, Francis B, Fioravanti C, Gibson RE. Curr Opin Chem Biol 1999; 3: 388-394.
17. Korlipara VL, Takemori AE, Portoghese PS. J Med Chem 1994; 37: 1882-1885.
18. Akgün E, Sajjad M, Arnett CD, Portoghese PS. Abstracts of the 214th American Chemical Society Meeting, Las Vegas, NV, September 1997, MEDI 235.
19. Akgün E, Rottenberg DA, Portoghese PS. Abstracts of the 213th American Chemical Society Meeting, San Francisco, CA, April 1997:MEDI 238.
20. Lever JR, Kinter CM, Ravert HT, Musachio JL, Mathews WB, Dannals RF. J Label Compd Radiopharm 1995; 36: 137-146.
21. Illi VO. Synthesis 1979; 1: 136.
22. Wilson AA, Dannals RF, Ravert HT, Wagner Jr HN. J Label Compd Radiopharm 1990; 28: 1189-1199.
23. Damhout P, Cantineau R, Lemaire C, Plenevaux A, Christiaens L, Guillaume M. App Radiat Isot 1992; 43: 1265-1274.
24. Haka MS, Kilbourn MR, Watkins GL, Toorongian SA. J Label Compd Radiopharm 1989; 27: 823-833.
25. Iwata R, Pascali C, Bogni A, Horvath G, Kovas Z, Yanai K, Ido T. Appl Radiat Isot 2000; 52: 87-92.
26. Mathews WB, Kinter CM, Palma J, Daniels RV, Ravert HT, Dannals RF, Lever JR. J Label Compd Radiopharm 1999; 42: 43-54.
27. Prinster SC, Hague C, Hall RA. Pharmacol Rev 2005; 57: 289-298.
28. Portoghese PS, Sultana M, Takemori AE. Eur J Pharmacol 1988; 146: 185-186.
29. Portoghese PS, Sultana M, Takemori AE. J Med Chem 1990; 33: 1714-1720.
30. Kane BE, Nieto MJ, McCurdy CR, Ferguson DM. FEBS Journal 2006; 273: 1966-1974.
31. Cheng Y, Prussoff WH. Biochem Pharmacol 1973; 22: 3099-3108.